25 XP   0   0   10

Arch Therapeutics Inc
Buy, Hold or Sell?

Let's analyse Arch Therapeutics Inc together

PenkeI guess you are interested in Arch Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Arch Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Arch Therapeutics Inc

I send you an email if I find something interesting about Arch Therapeutics Inc.

Quick analysis of Arch Therapeutics Inc (30 sec.)










What can you expect buying and holding a share of Arch Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-2.02
Expected worth in 1 year
$-2.80
How sure are you?
37.5%

+ What do you gain per year?

Total Gains per Share
$-0.78
Return On Investment
-67.0%

For what price can you sell your share?

Current Price per Share
$1.16
Expected price per share
$0.6 - $2.07
How sure are you?
50%

1. Valuation of Arch Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)

$1.16

Intrinsic Value Per Share

$-11.40 - $-13.55

Total Value Per Share

$-13.42 - $-15.57

2. Growth of Arch Therapeutics Inc (5 min.)




Is Arch Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$9.5m-$4.2m-$3.5m-45.5%

How much money is Arch Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$1.9m-$1.3m-$584.6k-29.7%
Net Profit Margin-7,799.6%-47,829.4%--

How much money comes from the company's main activities?

3. Financial Health of Arch Therapeutics Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#955 / 1019

Most Revenue
#680 / 1019

Most Profit
#294 / 1019

Most Efficient
#940 / 1019

What can you expect buying and holding a share of Arch Therapeutics Inc? (5 min.)

Welcome investor! Arch Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Arch Therapeutics Inc.

What can you expect buying and holding a share of Arch Therapeutics Inc?

First you should know what it really means to hold a share of Arch Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Arch Therapeutics Inc is $1.16. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Arch Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Arch Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-2.02. Based on the TTM, the Book Value Change Per Share is $-0.19 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.31 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Arch Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.57-48.7%-0.46-39.9%-0.20-16.9%-0.14-11.7%-0.07-6.4%
Usd Book Value Change Per Share-0.44-37.6%-0.19-16.8%-0.31-26.5%-0.10-8.7%-0.05-4.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.44-37.6%-0.19-16.8%-0.31-26.5%-0.10-8.7%-0.05-4.3%
Usd Price Per Share7.24-3.76-0.05-0.88-0.65-
Price to Earnings Ratio-3.20--2.01--2.49--0.19--1.73-
Price-to-Total Gains Ratio-16.60--11.64--11.98-63.03-31.23-
Price to Book Ratio-3.59--2.20--2.58--67.30--20.97-
Price-to-Total Gains Ratio-16.60--11.64--11.98-63.03-31.23-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.16
Number of shares862
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.19-0.10
Usd Total Gains Per Share-0.19-0.10
Gains per Quarter (862 shares)-167.53-86.85
Gains per Year (862 shares)-670.11-347.41
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-670-6800-347-357
20-1340-13500-695-704
30-2010-20200-1042-1051
40-2680-26900-1390-1398
50-3351-33600-1737-1745
60-4021-40300-2084-2092
70-4691-47000-2432-2439
80-5361-53700-2779-2786
90-6031-60400-3127-3133
100-6701-67100-3474-3480

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.019.00.05.0%5.034.01.012.5%5.035.01.012.2%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%6.014.00.030.0%15.025.00.037.5%15.026.00.036.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.041.00.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%6.014.00.030.0%15.025.00.037.5%15.026.00.036.6%

Fundamentals of Arch Therapeutics Inc

About Arch Therapeutics Inc

Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. The company's flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. It is also involved in the development of AC5-G for gastrointestinal endoscopic procedures, and AC5-V and AC5 surgical hemostat for hemostasis inside the body. The company was founded in 2006 and is based in Framingham, Massachusetts.

Fundamental data was last updated by Penke on 2024-03-28 17:13:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Arch Therapeutics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Arch Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Arch Therapeutics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -5,846.6% means that $-58.47 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Arch Therapeutics Inc:

  • The MRQ is -5,846.6%. The company is making a huge loss. -2
  • The TTM is -7,799.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-5,846.6%TTM-7,799.6%+1,953.0%
TTM-7,799.6%YOY-47,829.4%+40,029.8%
TTM-7,799.6%5Y-19,311.5%+11,511.9%
5Y-19,311.5%10Y-9,655.7%-9,655.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-5,846.6%-197.2%-5,649.4%
TTM-7,799.6%-210.4%-7,589.2%
YOY-47,829.4%-279.3%-47,550.1%
5Y-19,311.5%-436.8%-18,874.7%
10Y-9,655.7%-599.3%-9,056.4%
1.1.2. Return on Assets

Shows how efficient Arch Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Arch Therapeutics Inc to the Biotechnology industry mean.
  • -147.2% Return on Assets means that Arch Therapeutics Inc generated $-1.47 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Arch Therapeutics Inc:

  • The MRQ is -147.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -111.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-147.2%TTM-111.5%-35.7%
TTM-111.5%YOY-74.7%-36.7%
TTM-111.5%5Y-59.3%-52.2%
5Y-59.3%10Y-50.5%-8.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-147.2%-13.6%-133.6%
TTM-111.5%-12.9%-98.6%
YOY-74.7%-11.9%-62.8%
5Y-59.3%-14.2%-45.1%
10Y-50.5%-16.2%-34.3%
1.1.3. Return on Equity

Shows how efficient Arch Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Arch Therapeutics Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means Arch Therapeutics Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Arch Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-16.8%+16.8%
5Y-16.8%10Y-54.3%+37.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--17.0%+17.0%
TTM--16.1%+16.1%
YOY--15.4%+15.4%
5Y-16.8%-20.0%+3.2%
10Y-54.3%-21.1%-33.2%

1.2. Operating Efficiency of Arch Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Arch Therapeutics Inc is operating .

  • Measures how much profit Arch Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Arch Therapeutics Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Arch Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-1,907.7%+1,907.7%
TTM-1,907.7%YOY-46,106.6%+44,199.0%
TTM-1,907.7%5Y-17,616.8%+15,709.1%
5Y-17,616.8%10Y-8,808.4%-8,808.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--286.1%+286.1%
TTM-1,907.7%-224.4%-1,683.3%
YOY-46,106.6%-288.4%-45,818.2%
5Y-17,616.8%-475.2%-17,141.6%
10Y-8,808.4%-624.7%-8,183.7%
1.2.2. Operating Ratio

Measures how efficient Arch Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 34.10 means that the operating costs are $34.10 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Arch Therapeutics Inc:

  • The MRQ is 34.102. The company is inefficient in keeping operating costs low. -1
  • The TTM is 58.934. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ34.102TTM58.934-24.833
TTM58.934YOY464.163-405.228
TTM58.9345Y185.400-126.466
5Y185.40010Y92.700+92.700
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ34.1022.997+31.105
TTM58.9343.247+55.687
YOY464.1633.766+460.397
5Y185.4005.675+179.725
10Y92.7007.857+84.843

1.3. Liquidity of Arch Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Arch Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.16 means the company has $0.16 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Arch Therapeutics Inc:

  • The MRQ is 0.159. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.182. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.159TTM0.182-0.023
TTM0.182YOY0.751-0.569
TTM0.1825Y3.094-2.912
5Y3.09410Y5.208-2.114
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1593.930-3.771
TTM0.1824.251-4.069
YOY0.7515.436-4.685
5Y3.0946.045-2.951
10Y5.2086.363-1.155
1.3.2. Quick Ratio

Measures if Arch Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Arch Therapeutics Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.00 means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Arch Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.001-0.001
TTM-5Y1.882-1.882
5Y1.88210Y4.494-2.613
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.629-3.629
TTM-4.065-4.065
YOY0.0015.397-5.396
5Y1.8825.993-4.111
10Y4.4946.277-1.783

1.4. Solvency of Arch Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Arch Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Arch Therapeutics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 6.26 means that Arch Therapeutics Inc assets are financed with 625.6% credit (debt) and the remaining percentage (100% - 625.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Arch Therapeutics Inc:

  • The MRQ is 6.256. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 5.556. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ6.256TTM5.556+0.700
TTM5.556YOY3.430+2.126
TTM5.5565Y2.570+2.986
5Y2.57010Y2.477+0.093
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.2560.332+5.924
TTM5.5560.334+5.222
YOY3.4300.268+3.162
5Y2.5700.366+2.204
10Y2.4770.390+2.087
1.4.2. Debt to Equity Ratio

Measures if Arch Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Arch Therapeutics Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Arch Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.473-0.473
5Y0.47310Y0.948-0.475
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.381-0.381
TTM-0.390-0.390
YOY-0.334-0.334
5Y0.4730.434+0.039
10Y0.9480.466+0.482

2. Market Valuation of Arch Therapeutics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Arch Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Arch Therapeutics Inc to the Biotechnology industry mean.
  • A PE ratio of -3.20 means the investor is paying $-3.20 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Arch Therapeutics Inc:

  • The EOD is -0.513. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.201. Based on the earnings, the company is expensive. -2
  • The TTM is -2.014. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.513MRQ-3.201+2.688
MRQ-3.201TTM-2.014-1.187
TTM-2.014YOY-2.488+0.474
TTM-2.0145Y-0.194-1.819
5Y-0.19410Y-1.734+1.539
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.513-2.315+1.802
MRQ-3.201-2.560-0.641
TTM-2.014-2.664+0.650
YOY-2.488-4.122+1.634
5Y-0.194-6.258+6.064
10Y-1.734-6.108+4.374
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Arch Therapeutics Inc:

  • The EOD is -1.594. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -9.951. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.521. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.594MRQ-9.951+8.357
MRQ-9.951TTM-5.521-4.430
TTM-5.521YOY-2.600-2.920
TTM-5.5215Y-5.907+0.387
5Y-5.90710Y-8.351+2.444
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.594-3.067+1.473
MRQ-9.951-3.251-6.700
TTM-5.521-3.545-1.976
YOY-2.600-5.595+2.995
5Y-5.907-8.315+2.408
10Y-8.351-8.708+0.357
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Arch Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -3.59 means the investor is paying $-3.59 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Arch Therapeutics Inc:

  • The EOD is -0.575. Based on the equity, the company is expensive. -2
  • The MRQ is -3.586. Based on the equity, the company is expensive. -2
  • The TTM is -2.195. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.575MRQ-3.586+3.011
MRQ-3.586TTM-2.195-1.390
TTM-2.195YOY-2.580+0.385
TTM-2.1955Y-67.295+65.100
5Y-67.29510Y-20.967-46.328
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.5751.905-2.480
MRQ-3.5862.111-5.697
TTM-2.1952.095-4.290
YOY-2.5802.836-5.416
5Y-67.2953.443-70.738
10Y-20.9673.794-24.761
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Arch Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.436-0.194-55%-0.308-29%-0.101-77%-0.050-88%
Book Value Per Share---2.019-1.660-18%-0.539-73%-0.442-78%-0.229-89%
Current Ratio--0.1590.182-12%0.751-79%3.094-95%5.208-97%
Debt To Asset Ratio--6.2565.556+13%3.430+82%2.570+143%2.477+153%
Debt To Equity Ratio----0%-0%0.473-100%0.948-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.565-0.463-18%-0.196-65%-0.135-76%-0.074-87%
Free Cash Flow Per Share---0.182-0.189+4%-0.124-32%-0.067-63%-0.039-78%
Free Cash Flow To Equity Per Share---0.0040.028-113%-0.003-21%0.005-167%0.005-168%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.975+3%
Intrinsic Value_10Y_max---13.555--------
Intrinsic Value_10Y_min---11.405--------
Intrinsic Value_1Y_max---0.562--------
Intrinsic Value_1Y_min---0.551--------
Intrinsic Value_3Y_max---2.295--------
Intrinsic Value_3Y_min---2.179--------
Intrinsic Value_5Y_max---4.760--------
Intrinsic Value_5Y_min---4.366--------
Market Cap5501137.600-524%34334715.36017831280.840+93%8563530.911+301%27712734.015+24%41364939.493-17%
Net Profit Margin---58.466-77.996+33%-478.294+718%-193.115+230%-96.557+65%
Operating Margin----19.0770%-461.0660%-176.1680%-88.0840%
Operating Ratio--34.10258.934-42%464.163-93%185.400-82%92.700-63%
Pb Ratio-0.575+84%-3.586-2.195-39%-2.580-28%-67.295+1777%-20.967+485%
Pe Ratio-0.513+84%-3.201-2.014-37%-2.488-22%-0.194-94%-1.734-46%
Price Per Share1.160-524%7.2403.760+93%0.047+15239%0.878+724%0.646+1021%
Price To Free Cash Flow Ratio-1.594+84%-9.951-5.521-45%-2.600-74%-5.907-41%-8.351-16%
Price To Total Gains Ratio-2.660+84%-16.605-11.641-30%-11.978-28%63.032-126%31.232-153%
Quick Ratio----0%0.001-100%1.882-100%4.494-100%
Return On Assets---1.472-1.115-24%-0.747-49%-0.593-60%-0.505-66%
Return On Equity----0%-0%-0.1680%-0.5430%
Total Gains Per Share---0.436-0.194-55%-0.308-29%-0.101-77%-0.050-88%
Usd Book Value---9575516.000-7871091.000-18%-4289139.750-55%-2781586.900-71%-1645965.825-83%
Usd Book Value Change Per Share---0.436-0.194-55%-0.308-29%-0.101-77%-0.050-88%
Usd Book Value Per Share---2.019-1.660-18%-0.539-73%-0.442-78%-0.229-89%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.565-0.463-18%-0.196-65%-0.135-76%-0.074-87%
Usd Free Cash Flow---862605.000-897819.250+4%-981903.750+14%-1183002.000+37%-1166321.250+35%
Usd Free Cash Flow Per Share---0.182-0.189+4%-0.124-32%-0.067-63%-0.039-78%
Usd Free Cash Flow To Equity Per Share---0.0040.028-113%-0.003-21%0.005-167%0.005-168%
Usd Market Cap5501137.600-524%34334715.36017831280.840+93%8563530.911+301%27712734.015+24%41364939.493-17%
Usd Price Per Share1.160-524%7.2403.760+93%0.047+15239%0.878+724%0.646+1021%
Usd Profit---2681652.000-1966108.000-27%-1381440.750-48%-1390977.300-48%-1454987.225-46%
Usd Revenue--45867.00028832.750+59%4304.500+966%7440.500+516%3720.250+1133%
Usd Total Gains Per Share---0.436-0.194-55%-0.308-29%-0.101-77%-0.050-88%
 EOD+2 -6MRQTTM+12 -17YOY+10 -205Y+10 -2110Y+9 -23

3.2. Fundamental Score

Let's check the fundamental score of Arch Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.513
Price to Book Ratio (EOD)Between0-1-0.575
Net Profit Margin (MRQ)Greater than0-58.466
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.159
Debt to Asset Ratio (MRQ)Less than16.256
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.472
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Arch Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5027.844
Ma 20Greater thanMa 501.699
Ma 50Greater thanMa 1002.097
Ma 100Greater thanMa 2003.965
OpenGreater thanClose1.100
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,822
Total Liabilities11,397
Total Stockholder Equity-9,576
 As reported
Total Liabilities 11,397
Total Stockholder Equity+ -9,576
Total Assets = 1,822

Assets

Total Assets1,822
Total Current Assets1,814
Long-term Assets7
Total Current Assets
Cash And Cash Equivalents 206
Inventory 1,336
Other Current Assets 273
Total Current Assets  (as reported)1,814
Total Current Assets  (calculated)1,814
+/-0
Long-term Assets
Property Plant Equipment 4
Long-term Assets Other 4
Long-term Assets  (as reported)7
Long-term Assets  (calculated)7
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities11,397
Long-term Liabilities0
Total Stockholder Equity-9,576
Total Current Liabilities
Short Long Term Debt 7,143
Accounts payable 2,772
Other Current Liabilities 139
Total Current Liabilities  (as reported)11,397
Total Current Liabilities  (calculated)10,055
+/- 1,343
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)-9,576
Total Stockholder Equity (calculated)0
+/- 9,576
Other
Capital Stock5
Common Stock Shares Outstanding 4,742
Net Debt 6,938
Net Invested Capital -2,432
Net Working Capital -9,583



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-30
> Total Assets 
1,587
995
2,673
1,835
877
824
606
3,318
4,003
2,868
1,759
5,903
5,144
3,902
7,579
6,323
6,090
5,043
3,467
6,599
4,840
3,637
2,427
3,791
2,902
3,566
2,895
3,166
2,151
2,100
6,853
4,996
3,676
2,544
1,439
1,573
2,604
1,716
1,593
1,564
1,958
1,822
1,8221,9581,5641,5931,7162,6041,5731,4392,5443,6764,9966,8532,1002,1513,1662,8953,5662,9023,7912,4273,6374,8406,5993,4675,0436,0906,3237,5793,9025,1445,9031,7592,8684,0033,3186068248771,8352,6739951,587
   > Total Current Assets 
1,577
985
2,662
1,835
877
824
606
3,318
0
2,868
1,759
5,903
5,144
3,898
7,576
6,320
6,079
5,029
3,448
6,577
4,819
3,618
2,409
3,776
2,890
3,553
2,884
3,157
2,143
2,092
6,842
4,986
3,668
2,536
1,432
1,567
2,598
1,711
1,588
1,560
1,950
1,814
1,8141,9501,5601,5881,7112,5981,5671,4322,5363,6684,9866,8422,0922,1433,1572,8843,5532,8903,7762,4093,6184,8196,5773,4485,0296,0796,3207,5763,8985,1445,9031,7592,86803,3186068248771,8352,6629851,577
       Cash And Cash Equivalents 
557
945
2,631
1,803
834
783
574
3,274
3,960
2,815
1,669
5,745
5,036
3,788
7,230
6,169
5,994
4,958
3,378
6,489
4,667
3,378
1,956
3,182
2,180
3,023
1,789
2,013
959
879
5,561
3,779
2,267
1,088
54
55
747
11
29
87
223
206
20622387291174755541,0882,2673,7795,5618799592,0131,7893,0232,1803,1821,9563,3784,6676,4893,3784,9585,9946,1697,2303,7885,0365,7451,6692,8153,9603,2745747838341,8032,631945557
       Net Receivables 
1,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000001,000
       Other Current Assets 
20
40
31
32
43
42
32
44
43
53
90
158
108
110
345
151
85
71
70
88
152
240
453
595
0
330
141
166
216
197
453
379
0
10
0
0
0
289
156
91
363
273
273363911562890001003794531972161661413300595453240152887071851513451101081589053434432424332314020
   > Long-term Assets 
10
10
10
0
0
0
0
0
0
0
0
0
0
4
4
3
11
13
19
23
21
19
17
14
13
13
11
10
8
8
10
10
9
8
7
6
6
5
5
4
8
7
78455667891010881011131314171921231913113440000000000101010
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
4
4
3
7
10
15
19
17
15
14
11
9
10
8
6
5
4
7
6
5
4
4
3
2
1
1
1
5
4
45111234456745681091114151719151073440000000000000
       Long-term Assets Other 
10
10
10
0
0
0
0
0
0
0
0
0
0
0
0
0
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
444444444444444444444444440000000000000101010
> Total Liabilities 
1,400
1,485
11,161
9,732
7,769
6,251
6,535
9,383
2,463
1,959
1,642
1,958
1,983
1,410
2,997
2,940
3,864
1,929
1,392
4,349
3,480
4,301
2,627
3,962
3,710
3,667
3,430
3,489
3,652
4,669
4,801
4,380
4,702
4,967
4,499
5,589
6,797
7,605
7,979
9,579
9,466
11,397
11,3979,4669,5797,9797,6056,7975,5894,4994,9674,7024,3804,8014,6693,6523,4893,4303,6673,7103,9622,6274,3013,4804,3491,3921,9293,8642,9402,9971,4101,9831,9581,6421,9592,4639,3836,5356,2517,7699,73211,1611,4851,400
   > Total Current Liabilities 
456
513
4,369
3,460
2,724
995
1,392
1,892
1,286
749
399
682
1,879
1,410
363
370
434
471
392
359
288
277
281
270
714
631
817
555
646
742
1,847
1,446
1,728
1,952
1,444
1,919
3,320
4,145
7,979
9,579
9,466
11,397
11,3979,4669,5797,9794,1453,3201,9191,4441,9521,7281,4461,8477426465558176317142702812772883593924714343703631,4101,8796823997491,2861,8921,3929952,7243,4604,369513456
       Short-term Debt 
0
0
4,115
3,078
2,280
421
859
910
0
334
100
0
900
755
0
0
0
0
0
0
0
0
0
0
0
0
0
68
37
57
1,117
1,000
0
0
0
0
0
1,890
0
0
0
0
00001,890000001,0001,1175737680000000000000755900010033409108594212,2803,0784,11500
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
755
0
0
0
0
0
0
0
0
0
0
0
0
0
68
37
57
117
0
1,000
0
0
0
550
1,000
1,981
3,092
5,628
7,143
7,1435,6283,0921,9811,0005500001,000011757376800000000000007550000000000000
       Accounts payable 
456
513
254
382
444
574
534
982
232
414
299
682
979
655
363
370
434
471
392
359
288
277
281
129
534
402
724
302
609
685
730
446
408
749
1,288
1,696
1,328
2,255
2,426
2,471
2,304
2,772
2,7722,3042,4712,4262,2551,3281,6961,288749408446730685609302724402534129281277288359392471434370363655979682299414232982534574444382254513456
       Other Current Liabilities 
0
203
4,265
3,294
2,548
701
778
893
580
215
163
189
604
383
154
164
168
181
75
176
127
146
0
0
0
0
0
0
0
0
1,000
1,000
1,000
1,000
0
0
748
890
35
0
243
139
139243035890748001,0001,0001,0001,00000000000146127176751811681641543836041891632155808937787012,5483,2944,2652030
   > Long-term Liabilities 
945
972
6,792
6,272
5,046
5,256
5,143
7,491
0
1,210
1,243
1,276
104
0
2,635
2,569
3,430
1,458
1,000
3,990
3,192
4,024
2,347
3,692
2,996
3,036
2,613
2,934
3,005
3,927
2,954
2,934
2,975
3,015
3,054
3,669
3,476
3,460
0
0
0
0
00003,4603,4763,6693,0543,0152,9752,9342,9543,9273,0052,9342,6133,0362,9963,6922,3474,0243,1923,9901,0001,4583,4302,5692,63501041,2761,2431,21007,4915,1435,2565,0466,2726,792972945
       Long term Debt Total 
0
947
0
953
956
959
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
108
139
1,719
1,660
1,600
0
0
0
0
0
0
0
0
0
0
00000000001,6001,6601,71913910800000000000000000000095995695309470
       Long-term Liabilities Other 
945
25
6,792
75
100
125
5,143
7,491
0
1,210
1,243
1,276
104
0
2,635
2,569
3,430
1,458
1,000
0
0
0
0
0
0
0
0
550
550
0
87
127
0
0
0
575
0
3,460
0
0
0
0
00003,4600575000127870550550000000001,0001,4583,4302,5692,63501041,2761,2431,21007,4915,143125100756,79225945
       Deferred Long Term Liability 
0
0
0
5,244
3,990
4,172
0
0
0
0
0
0
0
0
0
0
0
0
0
3,990
3,192
4,024
2,347
3,692
0
3,036
2,613
2,276
2,316
2,207
1,207
1,207
0
0
0
0
0
0
0
0
0
0
00000000001,2071,2072,2072,3162,2762,6133,03603,6922,3474,0243,1923,99000000000000004,1723,9905,244000
> Total Stockholder Equity
187
-490
-8,489
-7,897
-6,892
-5,426
-5,929
-6,065
1,540
910
118
3,945
3,161
2,492
4,582
3,384
2,227
3,114
2,075
2,251
1,360
-664
-201
-172
-807
-101
-536
-323
-1,500
-2,569
2,052
616
-1,026
-2,424
-3,059
-4,015
-4,193
-5,889
-6,386
-8,015
-7,508
-9,576
-9,576-7,508-8,015-6,386-5,889-4,193-4,015-3,059-2,424-1,0266162,052-2,569-1,500-323-536-101-807-172-201-6641,3602,2512,0753,1142,2273,3844,5822,4923,1613,9451189101,540-6,065-5,929-5,426-6,892-7,897-8,489-490187
   Common Stock
60
60
72
72
72
76
76
93
107
109
110
131
134
136
147
147
150
150
150
151
160
162
164
173
173
187
187
192
193
193
237
237
237
237
237
237
250
1
0
1
0
0
001012502372372372372372371931931921871871731731641621601511501501501471471361341311101091079376767272726060
   Retained Earnings Total Equity0000-56,87300000-48,032-46,502-44,711-43,556-42,161-41,257-40,5250-38,037-36,748-36,918-34,317-32,882-30,670-29,114-29,503-26,761-24,986-23,116-21,715-19,898-18,132-16,8790-14,625-13,230-12,396-12,775-13,410-13,820-5,440-4,632
   Accumulated Other Comprehensive Income 000000000000000000000000000000000000000000
   Capital Surplus 
4,759
4,890
5,260
5,440
5,810
6,893
7,224
8,566
0
17,680
18,139
23,712
24,741
25,472
29,420
29,998
31,580
32,078
32,594
32,845
35,517
36,091
36,383
37,693
0
40,237
40,534
41,646
41,863
41,949
48,317
48,411
0
0
0
0
0
50,983
0
0
0
0
000050,9830000048,41148,31741,94941,86341,64640,53440,237037,69336,38336,09135,51732,84532,59432,07831,58029,99829,42025,47224,74123,71218,13917,68008,5667,2246,8935,8105,4405,2604,8904,759
   Treasury Stock000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
-100
0
0
0
0
0
0
0
0
0
0
0
2,138
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000002,13800000000000-1000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-09-30)

Gross Profit (+$)
totalRevenue76
Cost of Revenue-78
Gross Profit-2-2
 
Operating Income (+$)
Gross Profit-2
Operating Expense-5,120
Operating Income-5,044-5,123
 
Operating Expense (+$)
Research Development671
Selling General Administrative4,371
Selling And Marketing Expenses0
Operating Expense5,1205,042
 
Net Interest Income (+$)
Interest Income0
Interest Expense-3,097
Other Finance Cost-0
Net Interest Income-3,097
 
Pretax Income (+$)
Operating Income-5,044
Net Interest Income-3,097
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-6,983-6,203
EBIT - interestExpense = -3,097
-6,983
-3,886
Interest Expense3,097
Earnings Before Interest and Taxes (EBIT)0-3,886
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-6,983
Tax Provision-0
Net Income From Continuing Ops-6,983-6,983
Net Income-6,983
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net1,1583,097
 

Technical Analysis of Arch Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Arch Therapeutics Inc. The general trend of Arch Therapeutics Inc is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Arch Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Arch Therapeutics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.31 < 1.76 < 2.07.

The bearish price targets are: 1 > 0.6 > 0.6.

Tweet this
Arch Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Arch Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Arch Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Arch Therapeutics Inc. The current macd is -0.27858023.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Arch Therapeutics Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Arch Therapeutics Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Arch Therapeutics Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Arch Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartArch Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Arch Therapeutics Inc. The current adx is 23.40.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Arch Therapeutics Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Arch Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Arch Therapeutics Inc. The current sar is 2.05681253.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Arch Therapeutics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Arch Therapeutics Inc. The current rsi is 27.84. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 2/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending up: The RSI is trending up. +1
Arch Therapeutics Inc Daily Relative Strength Index (RSI) ChartArch Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Arch Therapeutics Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Arch Therapeutics Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Arch Therapeutics Inc Daily Stochastic Oscillator ChartArch Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Arch Therapeutics Inc. The current cci is -169.33586338.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Arch Therapeutics Inc Daily Commodity Channel Index (CCI) ChartArch Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Arch Therapeutics Inc. The current cmo is -55.81150731.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Arch Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartArch Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Arch Therapeutics Inc. The current willr is -93.81443299.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Arch Therapeutics Inc Daily Williams %R ChartArch Therapeutics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Arch Therapeutics Inc.

Arch Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Arch Therapeutics Inc. The current atr is 0.19520744.

Arch Therapeutics Inc Daily Average True Range (ATR) ChartArch Therapeutics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Arch Therapeutics Inc. The current obv is -11,543,873.

Arch Therapeutics Inc Daily On-Balance Volume (OBV) ChartArch Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Arch Therapeutics Inc. The current mfi is 37.31.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Arch Therapeutics Inc Daily Money Flow Index (MFI) ChartArch Therapeutics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Arch Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-24ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-11ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-30BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-26RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-11BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Arch Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Arch Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5027.844
Ma 20Greater thanMa 501.699
Ma 50Greater thanMa 1002.097
Ma 100Greater thanMa 2003.965
OpenGreater thanClose1.100
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Arch Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Arch Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Arch Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Arch Therapeutics Inc

I send you an email if I find something interesting about Arch Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Arch Therapeutics Inc.

Receive notifications about Arch Therapeutics Inc in your mailbox!